Report Detail

Request for Sample of this report

Other Global Celecoxib Market Size study, by Product (50mg Celecoxib, 100mg Celecoxib, 200mg Celecoxib, 400mg Celecoxib), by End-User/Application (Rheumatoid Arthritis, Osteoarthritis, Acute Pain, Musculoskeletal Pain) and Regional Forecasts 2018-2025

  • RnM2739592
    • |
  • 08 January, 2019
    • |
  • Global
    • |
  • 200 Pages
    • |
  • Bizwit Research & Consulting LLP
    • |
  • Other

Global Celecoxib Market to reach USD XX billion by 2025.

Global Celecoxib Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Celecoxib Market is continuously growing in global scenario over the coming years. The major driving factor of global Celecoxib market is increasing prevalence of acute pains and musculoskeletal pain in adults. Acute pain and musculoskeletal pain are necessary to treat as they affect the body of humans which results in positive impact in the growth of the market. Moreover, growing demand from end user industries is also a factor which drives the market of celecoxib. The one of the major restraining factor of global celecoxib market is restrictive use of its relative complications. Celecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug. It is used to treat the pain and inflammation of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain in adult, painful menstruation and juvenile rheumatoid arthritis in people two years or older. Celecoxib is available by prescription in capsule form. Celecoxib offers various advantages such as it provides relief in pains, reduce swelling, reduce stiffness & discomfort associated with diseases and safe to use at higher risk for stomach related side effects. The regional analysis of Global Celecoxib Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
+K19
The major market player included in this report are:
• Pfizer.
• Shire
• Teva
• Mylan
• Chengdu Suncadia Pharmaceutical
• Jiangsu Chiatai Qingjiang Pharmaceutical
• Anhui Heyi Chemical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

 50mg Celecoxib
 100mg Celecoxib
 200mg Celecoxib
 400mg Celecoxib

By End-User/Application:

 Rheumatoid Arthritis
 Osteoarthritis
 Acute Pain
 Musculoskeletal Pain

By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Celecoxib Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors


TABLE OF CONTENTS

    Chapter 1. Executive Summary

    • 1.1. Market Snapshot
    • 1.2. Key Trends
    • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
      • 1.3.1. Celecoxib Market, by Product, 2015-2025 (USD Billion)
      • 1.3.2. Celecoxib Market, by End-User/Application, 2015-2025 (USD Billion)
      • 1.3.3. Celecoxib Market, by Region, 2015-2025 (USD Billion)
    • 1.4. Estimation Methodology
    • 1.5. Research Assumption

    Chapter 2. Celecoxib Market Definition and Scope

    • 2.1. Objective of the Study
    • 2.2. Market Definition & Scope
      • 2.2.1. Industry Evolution
      • 2.2.2. Scope of the Study
    • 2.3. Years Considered for the Study
    • 2.4. Currency Conversion Rates

    Chapter 3. Celecoxib Market Dynamics

    • 3.1. See Saw Analysis
      • 3.1.1. Market Drivers
      • 3.1.2. Market Challenges
      • 3.1.3. Market Opportunities

    Chapter 4. Celecoxib Market Industry Analysis

    • 4.1. Porter’s 5 Force Model
      • 4.1.1. Bargaining Power of Buyers
      • 4.1.2. Bargaining Power of Suppliers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
      • 4.1.6. Futuristic Approach to Porter’s 5 Force Model
    • 4.2. PEST Analysis
      • 4.2.1. Political Scenario
      • 4.2.2. Economic Scenario
      • 4.2.3. Social Scenario
      • 4.2.4. Technological Scenario
    • 4.3. Value Chain Analysis
      • 4.3.1. Supplier
      • 4.3.2. Manufacturers/Service Provider
      • 4.3.3. Distributors
      • 4.3.4. End-Users
    • 4.4. Key Buying Criteria
    • 4.5. Regulatory Framework
    • 4.6. Cost Structure Analysis
      • 4.6.1. Raw Material Cost Analysis
      • 4.6.2. Manufacturing Cost Analysis
      • 4.6.3. Labour Cost Analysis
    • 4.7. Investment Vs Adoption Scenario
    • 4.8. Analyst Recommendation & Conclusion

    Chapter 5. Celecoxib Market, by Product

    • 5.1. Market Snapshot
    • 5.2. Market Performance - Potential Model
    • 5.3. Key Market Players
    • 5.4. Celecoxib Market, Sub Segment Analysis
      • 5.4.1. 50mg Celecoxib
        • 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        • 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.2. 100mg Celecoxib
        • 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        • 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.3. 200mg Celecoxib
        • 5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        • 5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.4. 400mg Celecoxib
        • 5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
        • 5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

      Chapter 6. Celecoxib Market, by End-User/Application

      • 6.1. Market Snapshot
      • 6.2. Market Performance - Potential Model
      • 6.3. Key Market Players
      • 6.4. Celecoxib Market, Sub Segment Analysis
        • 6.4.1. Rheumatoid Arthritis
          • 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 6.4.2. Osteoarthritis
          • 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 6.4.3. Acute Pain
          • 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 6.4.4. Musculoskeletal Pain
          • 6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 6.4.5. Others
          • 6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
          • 6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

        Chapter 7. Celecoxib Market, by Regional Analysis

        • 7.1. Celecoxib Market, Regional Market Snapshot (2015-2025)
        • 7.2. North America Celecoxib Market Snapshot
          • 7.2.1. U.S.
            • 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.2.2. Canada
            • 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 7.3. Europe Celecoxib Market Snapshot
          • 7.3.1. U.K.
            • 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.3.2. Germany
            • 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.3.3. France
            • 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.3.4. Rest of Europe
            • 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 7.4. Asia Celecoxib Market Snapshot
          • 7.4.1. China
            • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.4.2. India
            • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.4.3. Japan
            • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.4.4. Rest of Asia Pacific
            • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 7.5. Latin America Celecoxib Market Snapshot
          • 7.5.1. Brazil
            • 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.5.2. Mexico
            • 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
        • 7.6. Rest of The World
          • 7.6.1. South America
            • 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
          • 7.6.2. Middle East and Africa
            • 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
            • 7.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)

          Chapter 8. Competitive Intelligence

          • 8.1. Company Market Share (Subject to Data Availability)
          • 8.2. Top Market Strategies
          • 8.3. Company Profiles
            • 8.3.1. Pfizer.
              • 8.3.1.1. Overview
              • 8.3.1.2. Financial (Subject to Data Availability)
              • 8.3.1.3. Product Summary
              • 8.3.1.4. Recent Developments
            • 8.3.2. Shire
            • 8.3.3. Teva
            • 8.3.4. Mylan
            • 8.3.5. Chengdu Suncadia Pharmaceutical
            • 8.3.6. Jiangsu Chiatai Qingjiang Pharmaceutical
            • 8.3.7. Anhui Heyi Chemical

          Chapter 9. Research Process

          • 9.1. Research Process
            • 9.1.1. Data Mining
            • 9.1.2. Analysis
            • 9.1.3. Market Estimation
            • 9.1.4. Validation
            • 9.1.5. Publishing

    Summary:
    Get latest Market Research Reports on Celecoxib . Industry analysis & Market Report on Celecoxib is a syndicated market report, published as Global Celecoxib Market Size study, by Product (50mg Celecoxib, 100mg Celecoxib, 200mg Celecoxib, 400mg Celecoxib), by End-User/Application (Rheumatoid Arthritis, Osteoarthritis, Acute Pain, Musculoskeletal Pain) and Regional Forecasts 2018-2025. It is complete Research Study and Industry Analysis of Celecoxib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,950.00
    		$5,550.00
    		3,053.35
    		4,290.15
    		3,677.45
    		5,167.05
    		603,125.50
    		847,429.50
    		333,380.00
    		468,420.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo